{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:56:10Z","timestamp":1780919770002,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ctim.2022.102873","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T09:22:22Z","timestamp":1661246542000},"page":"102873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Functional gastrointestinal disorders in children: Effectivity, safety, and tolerability of the herbal preparation STW-5 (Iberogast\u00ae) in general practice"],"prefix":"10.1016","volume":"71","author":[{"given":"Radke","family":"Michael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinson","family":"Bettina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehmann","family":"Eckehard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2022.102873_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jpeds.2018.03.037","article-title":"Prevalence of functional gastrointestinal disorders in children and adolescents: comparison between Rome III and Rome IV criteria","volume":"199","author":"Saps","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.ctim.2022.102873_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/nmo.12542","article-title":"Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009","volume":"27","author":"Park","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.ctim.2022.102873_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015594","article-title":"The costs of functional gastrointestinal disorders and related signs and symptoms in infants: a systematic literature review and cost calculation for England","volume":"7","author":"Mahon","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ctim.2022.102873_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/000992287801700208","article-title":"Recurrent abdominal pain in children: a retrospective survey of 119 patients","volume":"17","author":"Liebman","year":"1978","journal-title":"Clin Pediatr"},{"issue":"2","key":"10.1016\/j.ctim.2022.102873_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12519-009-0021-6","article-title":"Functional gastrointestinal disorders: past and present","volume":"5","author":"Ammoury","year":"2009","journal-title":"World J Pediatr"},{"key":"10.1016\/j.ctim.2022.102873_bib6","series-title":"Rome III: The Functional Gastrointestinal Disorders","year":"2006"},{"issue":"5","key":"10.1016\/j.ctim.2022.102873_bib7","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctim.2022.102873_bib8","series-title":"Schule und Gleichaltrigengruppe","article-title":"Psychosoziale Belastungen im Jugendalter. Empirische Befunde zum Einflu\u00df von Familie","author":"Engel","year":"1989"},{"issue":"7","key":"10.1016\/j.ctim.2022.102873_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3928\/00904481-20090622-10","article-title":"Environmental factors of abdominal pain","volume":"38","author":"Chogle","year":"2009","journal-title":"Pediatr Ann"},{"issue":"5","key":"10.1016\/j.ctim.2022.102873_bib10","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/j.gastro.2005.08.063","article-title":"Childhood functional gastrointestinal disorders: child\/adolescent","volume":"130","author":"Rasquin","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctim.2022.102873_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2001-16142","article-title":"Ein Phytotherapeutikum und seine modifizierte Rezeptur bei funktioneller Dyspepsie","volume":"39","author":"Madisch","year":"2001","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102873_bib12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2036.2004.02275.x","article-title":"Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast)","volume":"20","author":"Melzer","year":"2004","journal-title":"Aliment Pharm Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.ctim.2022.102873_bib13","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1159\/000485410","article-title":"STW 5 (Iberogast) therapy in gastrointestinal functional disorders","volume":"35","author":"Malfertheiner","year":"2017","journal-title":"Dig Dis"},{"key":"10.1016\/j.ctim.2022.102873_bib14","series-title":"Integrated Study Report PFK CR-III-003-94 G Biometrical Part [Report No. 1]","author":"Schnitker","year":"1999"},{"issue":"6","key":"10.1016\/j.ctim.2022.102873_bib15","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1572-0241.2006.01183.x","article-title":"STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicentre, placebo-controlled double-blind study","volume":"102","author":"von Arnim","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ctim.2022.102873_bib16","first-page":"45","article-title":"Wirksamkeit und Vertr\u00e4glichkeit von Iberogast bei Patienten mit gesicherter Non Ulcus Dyspepsie","volume":"15","author":"Buchert","year":"1994","journal-title":"Z Phytother"},{"issue":"6","key":"10.1016\/j.ctim.2022.102873_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-2002-32130","article-title":"A randomised clinical trial comparing the efficacy of herbal preparation STW-5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia","volume":"40","author":"R\u00f6sch","year":"2002","journal-title":"Z Gastroenterol"},{"issue":"3","key":"10.1016\/j.ctim.2022.102873_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2036.2004.01859.x","article-title":"Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomised, placebo-controlled, multi-centre trial","volume":"19","author":"Madisch","year":"2004","journal-title":"Aliment Pharm Ther"},{"issue":"Suppl. 2","key":"10.1016\/j.ctim.2022.102873_bib19","first-page":"S91","article-title":"Efficacy and tolerability of the herbal preparation Iberogast\u00ae in the therapy of functional dyspepsia","volume":"7","author":"Sassin","year":"2000","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ctim.2022.102873_bib20","first-page":"P25","article-title":"Anwendungsbeobachtung zur Wirksamkeit und Vertr\u00e4glichkeit von Iberogast\u00ae in der Therapie des Colon irritabile","volume":"125","author":"Klein-Galczinsky","year":"1999","journal-title":"Phytother der Schwelle zum neuen Jahr (Abstr)"},{"issue":"83","key":"10.1016\/j.ctim.2022.102873_bib21","first-page":"1130","article-title":"Evaluating the multitarget effects of combinations through multistep clustering of pharmacological data: the example of the commercial preparation Iberogast","volume":"2017","author":"Abdel-Aziz","year":"2017","journal-title":"Planta Med"},{"key":"10.1016\/j.ctim.2022.102873_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10354-007-0429-3","article-title":"STW 5\/Iberogast: multi-Target-Wirkung bei funktioneller Dyspepsie und Reizdarmsyndrom","volume":"157","author":"Allescher","year":"2007","journal-title":"Wien Med Woche"},{"issue":"4","key":"10.1016\/j.ctim.2022.102873_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2036.2005.02572.x","article-title":"Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia","volume":"22","author":"Adam","year":"2005","journal-title":"Aliment Pharm Ther"},{"issue":"4","key":"10.1016\/j.ctim.2022.102873_bib24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1023\/B:DDAS.0000026317.00071.75","article-title":"Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia: a randomised, double-blind placebo-controlled crossover study","volume":"49","author":"Holtmann","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ctim.2022.102873_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10354-017-0578-y","article-title":"Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders: a non-interventional study with Iberogast\u00ae","volume":"168","author":"Raedsch","year":"2018","journal-title":"Wien Med Woche"},{"issue":"Suppl. 5","key":"10.1016\/j.ctim.2022.102873_bib26","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.phymed.2006.03.020","article-title":"Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus, and antrum","volume":"13","author":"Schemann","year":"2006","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.ctim.2022.102873_bib27","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1572-0241.2007.01142.x","article-title":"Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility, and gastric emptying in healthy men","volume":"102","author":"Pilichiewicz","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102873_bib28","unstructured":"Schemann M. Iberogast\u00ae \u2013 Focus regionenspezifische Motilit\u00e4t. Iberogast\u00ae Symposium. Bad W\u00f6rishofen, Germany; 2010."},{"issue":"11","key":"10.1016\/j.ctim.2022.102873_bib29","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1365-2982.2008.01242.x","article-title":"The multi-herbal drug STW 5 (Iberogast) has prosecretory action in the human intestine","volume":"21","author":"Krueger","year":"2009","journal-title":"Neurogastroenterol Motil"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229922000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229922000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:17:41Z","timestamp":1760807861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229922000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"alternative-id":["S0965229922000759"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2022.102873","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional gastrointestinal disorders in children: Effectivity, safety, and tolerability of the herbal preparation STW-5 (Iberogast\u00ae) in general practice","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2022.102873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102873"}}